Apixaban Teva GmbH 2

DRUG2 trials

Sponsors

Karolinska University Hospital, Medical University Of Silesia Katowice Poland, Centre Hospitalier Universitaire De Saint Etienne

Conditions

Atrial fibrillation and Chronic Kidney Disease stage 5Thromboembolism prophylaxis

Phase 3

Stroke prophylaxis with Apixaban in Chronic Kidney Disease stage 5 patients with Atrial fibrillation (SACK)

RecruitingCTIS2022-501600-10-00

Karolinska University Hospital, Medical University Of Silesia Katowice PolandAtrial fibrillation and Chronic Kidney Disease stage 5

Start: 2023-02-07Target: 1280Updated: 2025-12-08

Phase 4

Comparison of the effects of prophylactic administration of Apixaban on thrombin generation in patients with de novo multiple myeloma and patients undergoing a surgery for total knee replacement: the ProApix Study

RecruitingCTIS2024-515329-27-00

Centre Hospitalier Universitaire De Saint EtienneThromboembolism prophylaxis

Start: 2025-06-24Target: 32Updated: 2025-05-14